Material Agreements

Bunker Hill Mining Corp. entered into Warrant Indenture with Computershare Trust Company of Canada valued at Governs issuance and management of warrants; each whole warrant exercisable at C$0.30 per share on o (effective 2026-03-05).

“In connection with the issuance of the Warrants, on March 5, 2026, the Company entered into a warrant indenture (the “ Warrant Indenture ”) with Computershare Trust Company of Canada, as warrant agent, to govern the issuance and management of the Warrants.”

Bunker Hill Mining Corp. entered into Subscriber Forms with Investors in LIFE Offering valued at Issuance of 159,735,000 LIFE Units at C$0.18 per Unit for gross proceeds of approximately C$33,752,3 (effective 2026-03-05).

“On March 5, 2026, the Company entered into a series of substantially similar subscriber forms (collectively, the “ Subscriber Forms ”) pursuant to which such investors acquired LIFE Units at the Offer Price.”

Bunker Hill Mining Corp. entered into Agency Agreement with Haywood Securities Inc., Roth Canada, Inc., BMO Capital Markets, Canaccord Genuity Corp. valued at aggregate cash fees of approximately C$1,627,110 and issuance of 9,039,500 non-transferable compensa (effective 2026-03-05).

“On March 5, 2026, the Company and Haywood, on its own behalf and on behalf of Roth Canada, Inc., BMO Capital Markets, and Canaccord Genuity Corp. (collectively, the “ Agents ”), entered into an agency agreement (the “ Agency Agreement ”), pursuant to which the Agents conducted the LIFE Offering.”

TPI COMPOSITES, INC entered into ECP Purchase Agreement with ECP Blade Holdings LLC valued at $20,000,000 in cash (effective 2026-03-06).

“On March 6, 2026, the Company and certain of its direct and indirect subsidiaries (collectively, the “ECP Seller Parties”) entered into a Stock and Asset Purchase Agreement (the “ECP Purchase Agreement”) with ECP Blade Holdings LLC (“ECP Buyer”).”

LiveOne, Inc. entered into Shares Issuance Agreement with Music and Entertainment Rights Licensing Independent Network Limited ("Merlin") valued at 500,000 shares of its common stock, $0.001 par value per share, at a deemed issued price of $7.50 pe (effective 2026-03-03).

“On March 3, 2026, LiveOne, Inc. (the “Company”), Slacker, Inc. (“Slacker”), the Company’s wholly owned subsidiary, and Music and Entertainment Rights Licensing Independent Network Limited (“Merlin”) entered into a Shares Issuance Agreement (the “Agreement”) pursuant to which the Company agreed to issue to Merlin 500,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “common stock”), at a deemed issued price of $7.50 per share.”

Sunoco LP entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $1,200 million aggregate principal amount of Senior Notes (5.375% due 2031 and 5.625% due 2034) (effective 2026-03-09).

“On March 9, 2026, Sunoco LP (NYSE: SUN) (the “ Partnership ”) completed a private offering to eligible purchasers (the “ Notes Offering ”) of (i) $600 million in aggregate principal amount of its 5.375% Senior Notes due 2031 (the “ 2031 Notes ”) and (ii) $600 million in aggregate principal amount of its 5.625% Senior Notes due 2034 (the “ 2034 Notes ” and, collectively with the 2031 Notes, the “ Notes ”), along with the related guarantees of the Notes.”

RELMADA THERAPEUTICS, INC. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at approximately $160.0 million (effective 2026-03-09).

“On March 9, 2026, Relmada Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) for a private placement (the “Private Placement”) with certain institutional and accredited investors (each, a “Purchaser” and collectively, the “Purchasers”).”

WYTEC INTERNATIONAL INC entered into 1800 Diagonal SPA with 1800 Diagonal Lending LLC valued at $71,300 (effective 2026-03-03).

“entered into a securities purchase agreement (the “1800 Diagonal SPA”) with 1800 Diagonal Lending LLC, a Virginia limited liability company (“1800 Diagonal”), which closed on March 3, 2026, pursuant to which Wytec sold 1800 Diagonal a promissory note in the principal amount of $71,300”

Envirotech Vehicles, Inc. entered into Warrants with YA II PN, Ltd. (effective 2026-03-06).

“the Company issued to the Buyer warrants to purchase up to 1,291,778 shares of Common Stock at an exercise price of $0.01 per share (the “Warrants”)”

Envirotech Vehicles, Inc. entered into Debentures with YA II PN, Ltd. valued at $11,000,000 (effective 2026-03-06).

“in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches with the purchase price of the Debentures in each tranche being equal to 96% of the Subscription Amount to be purchased.”

Envirotech Vehicles, Inc. entered into Purchase Agreement with YA II PN, Ltd. valued at $11,000,000 (effective 2026-03-06).

“On March 6, 2026, Envirotech Vehicles, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with YA II PN, Ltd. (the “Buyer”), pursuant to which the Company agreed to issue and sell to the Buyer, and the Buyer agreed to purchase from the Company, debentures (the “Debentures”) in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches”

REALLOYS INC. entered into Underwriting Agreement with Clear Street LLC (effective 2026-03-05).

“On March 5, 2026, REalloys Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Clear Street LLC”

Jaguar Health, Inc. terminated Warrant Termination Agreement with Uptown Capital, LLC, Streeterville Capital, LLC, Iliad Research and Trading, L.P. (effective 2026-03-06).

“On March 6, 2026, the Company entered into a warrant termination agreement (the “Warrant Termination Agreement”) with Uptown, Streeterville, and Iliad Research and Trading, L.P. (“Iliad”; and together with Uptown and Streeterville, collectively the “Investors”), pursuant to which, warrants exercisable into an aggregate of 48,211 shares of the Company’s voting common stock, par value $0.0001 per share (the “Common Stock”) previously issued by the Company to the Investors would be terminated.”

Jaguar Health, Inc. amended 2025 Note Amendment with Streeterville Capital, LLC valued at $7,048,021.86 (effective 2026-03-06).

“On March 6, 2026, the Company also entered into an amendment (the “2025 Note Amendment”) with Streeterville to the secured promissory note in the original principal amount of $10,810,000.00 (the “2025 Note”) issued by the Company to Streeterville on November 12, 2025 pursuant to that certain Note Purchase Agreement among the same parties dated as of the even date.”

Jaguar Health, Inc. amended 2021 Note Amendment No. 3 with Streeterville Capital, LLC valued at $6,596,304.11 (effective 2026-03-06).

“On March 6, 2026, the Company and Napo Pharmaceuticals, Inc., the Company’s wholly-owned subsidiary (“Napo” and together with the Company, the “Borrower”), entered into an amendment (the “2021 Note Amendment No. 3”) with Streeterville to the secured promissory note in the original principal amount of $6,220,812.50 (as amended, the “2021 Note”) issued by Borrower to Streeterville on January 19, 2021 pursuant to that certain Note Purchase Agreement among the same parties dated as of the even date.”

Jaguar Health, Inc. amended Streeterville 2022 Royalty Interest Global Amendment No. 4 with Streeterville Capital, LLC valued at $12,428,782.20 (effective 2026-03-06).

“On March 6, 2026, the Company also entered into an amendment (the “Streeterville 2022 Royalty Interest Global Amendment No. 4”) to the royalty interest in the original principal amount of $12 million, as amended (the “Streeterville 2022 Royalty Interest”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which, (i) the starting date for the Company to make the monthly Royalty Payment under the Streeterville 2022 Royalty Interest would be postponed from April 1, 2026 to July 1, 2026, and (ii) the Royalty Repayment Amount (as defined in the Streeterville 2022 Royalty Interest) would be reduced by ten percent.”

Jaguar Health, Inc. amended Uptown 2020 Royalty Interest Global Amendment No. 4 with Uptown Capital, LLC valued at $11,125,282.54 (effective 2026-03-06).

“On March 6, 2026, Jaguar Health, Inc. (the “Company”) entered into an amendment (the “Uptown 2020 Royalty Interest Global Amendment No. 4”) to the royalty interest in the original principal amount of $12 million, as amended (the “Uptown 2020 Royalty Interest”) with Uptown Capital, LLC (f/k/a Irving Park Capital, LLC; “Uptown”), as amended, pursuant to which, (i) the starting date for the Company to make the monthly Royalty Payment under the Uptown 2020 Royalty Interest would be postponed from April 1, 2026 to July 1, 2026, and (ii) the Royalty Repayment Amount (as defined in the Uptown 2020 Royalty Interest) would be reduced by ten percent.”

CACI INTERNATIONAL INC /DE/ amended Amendment No. 1 with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto valued at $800 million (effective 2026-03-09).

“On March 9, 2026, CACI International Inc (the “Company”) and certain of its subsidiaries entered into Amendment No. 1 (the “Amendment”) to that certain Credit Agreement, dated as of October 30, 2024 (as amended, the “Term Loan B Credit Agreement”), with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Amendment provides for an additional $800 million tranche of incremental term loans (the “Incremental Term B-2 Loans”) under the Term Loan B Credit Agreement with a maturity date of March 9, 2033.”

Ondas Inc. entered into Agreement and Plan of Merger with Mistral, Inc. and Shoshana Banai valued at Total consideration of $175,000,000 payable in shares of common stock, with portions escrowed and pa (effective 2026-03-08).

“On March 8, 2026, Ondas Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Agreement”), by and among the Company, Project Cyclone Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), Mistral, Inc., a Delaware corporation (“Mistral”), and Shoshana Banai (the “Stockholder”).”

SPRUCE BIOSCIENCES, INC. terminated Prior Sales Agreement with Jefferies LLC (effective 2026-03-09).

“(the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”). Under the Sales Agreement, the Company may offer and sell, from time to time, through Jefferies as its sales agent and/or principal, shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering amount not exceeding the Maximum Program Amount, as such term is defined in the Sales Agreement.”

SPRUCE BIOSCIENCES, INC. entered into Open Market Sale Agreement with Jefferies LLC (effective 2026-03-09).

“On March 9, 2026, Spruce Biosciences, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”).”

Midnight Gaming Corp entered into Omnibus Amendment to Outstanding Common Stock Purchase Warrants with holders of Midnight Warrants valued at Universal cashless exercise right added to all outstanding warrants without payment of stated cash e (effective 2026-03-08).

“On March 8, 2026, Midnight Gaming Corporation (the "Company") approved and executed an Omnibus Amendment to Outstanding Common Stock Purchase Warrants (the "Warrant Amendment").”

Optimum Communications, Inc. entered into Base Indenture with Wilmington Trust, National Association valued at $1,657.0 million (effective 2026-03-03).

“On March 3, 2026, Lightpath Fiber Issuer LLC (the “Issuer”) completed the previously announced securitization financing transaction and issued $1,657.0 million in aggregate principal amount of Secured Fiber Network Revenue Notes, Series 2026-1 (the “Notes”)”

Korro Bio, Inc. entered into subscription agreement with a number of institutional accredited investors valued at approximately $85.0 million (effective 2026-03-09).

“Korro Bio, Inc., or Korro, entered into a subscription agreement with a number of institutional accredited investors pursuant to which it agreed to sell and issue in a private placement”

Cannae Holdings, Inc. terminated Margin Loan Agreement with Bank of America, N.A. (effective 2026-03-06).

“prepaid in full all outstanding obligations under the Margin Loan Agreement, dated as of November 30, 2020 (as amended, the "Margin Loan Agreement"), among Cannae Funding A, as borrower, Bank of America, N.A., as administrative agent and calculation agent, and the lenders party thereto”

Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at an aggregate purchase price of $1,853,000 (effective 2026-03-09).

“On March 9, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”)”

Cannabist Co Holdings Inc. amended forbearance agreement with ad hoc group of noteholders (effective 2026-03-06).

“On March 6, 2026, The Cannabist Company Holdings Inc. (“The Cannabist Company” or “the Company”) announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to the previously announced forbearance agreement with the Company, have agreed to a further extension and to forbear from exercising any of their rights and remedies under the amended and restated indenture, as supplemented, governing the Notes and applicable law, until March 17, 2026.”

ABBOTT LABORATORIES entered into Pricing Agreement with Morgan Stanley & Co. LLC, Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC valued at $20,000,000,000 aggregate principal amount (effective 2026-02-23).

“The Notes were sold pursuant to a pricing agreement, dated February 23, 2026 (the “Pricing Agreement”), by and among Abbott, Morgan Stanley & Co. LLC, Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, for themselves and as representatives of the several other underwriters named therein.”

Talkspace, Inc. entered into Agreement and Plan of Merger with Universal Health Services, Inc. and UHS Merger Subsidiary, Inc. (effective 2026-03-09).

“On March 9, 2026, Talkspace, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Universal Health Services, Inc., a Delaware corporation (“ Parent ”), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“ Merger Sub ”).”

Belpointe PREP, LLC entered into BPOZ Tokeneke Note with 100 Tokeneke Road, LLC valued at $5,000,000 (effective 2026-03-03).

“On March 3, 2026, Belpointe PREP, LLC (“we,” “us,” “our” or the “Company”), through our indirect wholly-owned subsidiary BPOZ 100 Tokeneke Holding, LLC, a Connecticut limited liability company (“BPOZ Tokeneke”), made a loan (the “BPOZ Tokeneke Loan”) in the principal amount of $5,000,000, evidenced by a convertible promissory note (the “BPOZ Tokeneke Note”), to 100 Tokeneke Road, LLC, a Connecticut limited liability company (“Tokeneke Road”).”

Blue Owl Credit Income Corp. entered into Secured Credit Facility with Core Income Funding XI LLC, Bank of America, N.A., The Bank of New York Mellon Trust Company, National Association (effective 2026-03-05).

“entered into a Credit Agreement (the “Secured Credit Facility”), with Core Income Funding XI, as borrower, BOCA, as servicer, the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, The Bank of New York Mellon Trust Company, National Association, as collateral agent and as collateral custodian and Bank of America, N.A., as sole lead arranger and sole book manager.”

Blue Owl Credit Income Corp. entered into BOCIC Loan Sale Agreement with Owl Rock CLO XXIV, LLC valued at approximately $766.018 million (effective 2026-03-05).

“the Company entered into a loan sale agreement with the Issuer dated as of the Closing Date (the “BOCIC Loan Sale Agreement”), which provided for the contribution and sale of approximately $766.018 million funded par amount of middle market loans”

Blue Owl Credit Income Corp. entered into A-L Credit Agreement with The Bank of New York Mellon Trust Company, National Association valued at $53 million (effective 2026-03-05).

“The Class A-L Loans were borrowed under a credit agreement (the “A-L Credit Agreement”), dated as of the Closing Date, by and among the Issuer, as borrower, the lenders party thereto, and The Bank of New York Mellon Trust Company, National Association, as collateral trustee and loan agent.”

Blue Owl Credit Income Corp. entered into Indenture with The Bank of New York Mellon Trust Company, National Association valued at $800 million (effective 2026-03-05).

“On March 5, 2026 (the “Closing Date”), Blue Owl Credit Income Corp. (the “Company”) completed a $800 million term debt securitization transaction (the “CLO Transaction”)”

Verizon ABS II LLC entered into Underwriting Agreement with SMBC Nikko Securities America, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Mizuho Securities USA LLC (effective 2026-03-05).

“On March 5, 2026, Verizon Master Trust (the “ Trust ”), a Delaware statutory trust, and Cellco Partnership d/b/a Verizon Wireless (“ Cellco ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with SMBC Nikko Securities America, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Mizuho Securities USA LLC, acting on behalf of themselves and as representatives of the several underwriters named therein, for the sale of certain notes of Series 2026-1.”

Dave Inc./DE entered into Indenture with U.S. Bank Trust Company, National Association valued at $200 million aggregate principal amount (effective 2026-03-09).

“The Company issued the Notes under an indenture, dated as of March 9, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

Crescent Energy Co entered into Indenture with U.S. Bank Trust Company, National Association valued at $690 million aggregate principal amount (effective 2026-03-06).

“On March 6, 2026, Crescent Energy Company, a Delaware corporation (NYSE: CRGY) (the “Company”), issued $690 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2031”

Alternus Clean Energy, Inc. entered into unsecured 20% original issue discount secured promissory notes with certain investors (the "Purchasers") valued at aggregate principal amount of $1,250,000 (effective 2026-03-03).

“sold in a private placement (the “Offering”), unsecured 20% original issue discount secured promissory notes with an aggregate principal amount of $1,250,000 (the “Notes”)”

Alternus Clean Energy, Inc. entered into Subscription Agreements with certain investors (the "Purchasers") valued at aggregate gross proceeds to the Company were $1,000,000 (effective 2026-03-03).

“On March 3, 2026, Alternus Clean Energy, Inc., a Delaware corporation (the “Company”) entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “Purchasers”)”

CDT Equity Inc. entered into Securities Purchase Agreement with the Purchaser valued at total principal amount of up to $555,556 (effective 2026-03-03).

“arch 3, 2026, the Company entered into a Securities Purchase Agreement (the “Note Purchase Agreement”) with the Purchaser.”

CDT Equity Inc. amended Purchase Agreement with an institutional investor (the "Purchaser") (effective 2026-03-03).

“the Company and Purchaser entered into an amendment to the Purchase Agreement (the "Amendment") in which the parties mutually agreed to lower the Floor Price (as defined in the Purchase Agreement) to $0.60.”

Ingram Micro Holding Corp entered into Share Repurchase Agreement with Ingram Holdco, LLC valued at $75 million (effective 2026-03-05).

“On March 5, 2026, the Company entered into a share repurchase agreement (the “Share Repurchase Agreement”) with the Selling Stockholder pursuant to which the Company agreed to separately repurchase directly from the Selling Stockholder an aggregate number of Shares equal to $75 million at the same net price paid to the Selling Stockholder by the Underwriters (the “Share Repurchase”).”

Ingram Micro Holding Corp entered into Underwriting Agreement with Ingram Holdco, LLC, Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC (effective 2026-03-05).

“On March 5, 2026, Ingram Micro Holding Company (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ingram Holdco, LLC (the “Selling Stockholder”), Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (collectively, the “Underwriting Representatives”) on their own behalf and as representatives of the other underwriters listed on Schedule I thereto (collectively, the “Underwriters”), pursuant to which the Selling Stockholder agreed to sell to the Underwriters, and the Underwriters agreed to purchase from the Selling Stockholder, subject to and upon the terms and conditions set forth therein, an aggregate of 8,988,764 shares (the “Shares”) of common stock, par value $0.01 per share of the Company (“Common Stock” and such sale and purchase, the “Offering”).”

Israel Acquisitions Corp amended Second BCA Amendment with Gadfin Ltd. valued at Revised Section 7.1(d) extending termination date to March 16, 2026 and removing automatic extension (effective 2025-12-31).

“On December 31, 2025, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel (“ NewPubco ”) entered into a second amendment to the BCA (the “ Second BCA Amendment ”).”

Israel Acquisitions Corp amended Administrative Services Agreement Waiver with Israel Acquisitions Sponsor LLC valued at Waiver of $10,000/month until business combination or liquidation and $240,000 accrued fees (effective 2025-12-31).

“On December 31, 2025, the Parties entered into a waiver to the Agreement (the “ Waiver ”) whereby the Parties agreed to waive the administrative fees due under the Agreement.”

dMY Squared Technology Group, Inc. entered into Additional PIPE Subscription Agreement with additional PIPE Investors valued at $1,450,000 (effective 2026-03-06).

“On March 6, 2026, dMY, Holdco, and Horizon entered into additional Subscription Agreements with additional PIPE Investors, pursuant to which Holdco has agreed to issue and sell, and the additional PIPE Investors agreed to subscribe for and purchase an additional $1,450,000 of PIPE Shares, at a per share price equal to the Redemption Price.”

Mag Magna Corp entered into Equity Purchase Agreement with Monroe Street Capital Partners, LP valued at Up to $30,000,000.00 of common stock; initial commitment of 15,000 shares; purchase price 80% of low (effective 2026-02-25).

“Item 1.01. Entry into a Material Definitive Agreement. Equity Purchase Agreement Effective February 25, 2026, Mag Magna Corp., a Wyoming corporation (the “Company” ), entered into an Equity Purchase Agreement (the “Purchase Agreement” ) with Monroe Street Capital Partners, LP ( “Monroe” ).”

enGene Therapeutics Inc. terminated Open Market Sale Agreement with Jefferies LLC valued at terminated Prior Sales Agreement; no shares sold (effective 2026-02-27).

“On February 27, 2026, the Company delivered written notice to Jefferies LLC that effective as of March 6, 2026, the Company terminated the Open Market Sale Agreement SM , dated as of December 20, 2024 (the “Prior Sales Agreement”), that the Company had previously entered into with Jefferies LLC, as sales agent.”

enGene Therapeutics Inc. entered into Sales Agreement with Leerink Partners LLC valued at up to $100,000,000 (effective 2026-03-09).

“On March 9, 2026, enGene Holdings Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (“Leerink Partners”), pursuant to which the Company may sell its common shares, without par value (the “Common Shares”), from time to time through Leerink Partners.”

Aureus Greenway Holdings Inc entered into Agreement and Plan of Merger with Autonomous Power Corporation (effective 2026-03-08).

“On March 8, 2026, Aureus Greenway Holdings Inc., a Nevada corporation (“ Parent ” or the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among Parent, Aureus Merger Sub Inc., a Delaware corporation and direct wholly owned subsidiary of Parent (“ Merger Sub ”), Autonomous Power Corporation, a Delaware corporation (“ Target ”), and Andrew Fox, solely in his capacity as the representative, agent and attorney-in-fact of the stockholders of Target (the “ Stockholder Representative ”).”